Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese

Pharmacogenetics. 1999 Jun;9(3):401-4. doi: 10.1097/00008571-199906000-00017.

Authors

T Katoh¹, H Inatomi, M Yang, T Kawamoto, T Matsumoto, D A Bell

Affiliation

¹ Department of Health Information Science, School of Health Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan. k-taka@health.uoeh-u.ac.jp

PMID: 10471074
DOI: 10.1097/00008571-199906000-00017

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aged
Arylamine N-Acetyltransferase / genetics*
Carcinoma, Transitional Cell / enzymology
Carcinoma, Transitional Cell / ethnology
Carcinoma, Transitional Cell / genetics*
Case-Control Studies
Female
Humans
Isoenzymes / genetics*
Japan
Male
Middle Aged
Polymerase Chain Reaction
Polymorphism, Restriction Fragment Length
Urologic Neoplasms / enzymology
Urologic Neoplasms / ethnology
Urologic Neoplasms / genetics*

Substances

Isoenzymes
Arylamine N-Acetyltransferase
N-acetyltransferase 1
NAT2 protein, human